{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 1b Study of Gilteritinib in Participants with Locally Advanced or Metastatic NSCLC with ALK Rearrangement After Prior Treatment with an ALK Inhibitor","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1b-study-of-gilteritinib-in-participants-with-locally-advanced-or-metastatic-nsclc-with-alk-rearrangement-after-prior-treatment-with-an-alk-inhibitor\/#breadcrumbitem"}]}